Cargando…

Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab

Belimumab (Benlysta(®)) is a fully humanized monoclonal antibody that inhibits B lymphocyte stimulator (BLyS, also known as B cell-activating factor of the tumor necrosis factor family) and was approved by the US Food and Drug Administration (FDA) and the European Medicines Evaluation Agency for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzman, Marla, Hui-Yuen, Joyce S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323799/
https://www.ncbi.nlm.nih.gov/pubmed/32612353
http://dx.doi.org/10.2147/DDDT.S216193